What were the conclusions of the NTM-NET Consensus Guidelines as far as the definition of treatment refractoriness in MAC lung disease, and what’s your assessment of these recommendations?

What were the conclusions of the NTM-NET Consensus Guidelines as far as the definition of treatment refractoriness in MAC lung disease, and what’s your assessment of these recommendations?

What were the conclusions of the NTM-NET Consensus Guidelines as far as the definition of treatment refractoriness in MAC lung disease, and what’s your assessment of these recommendations?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Shannon Kasperbauer, MD

Shannon Kasperbauer, MD

Associate Professor of Medicine
Department of Medicine
Division of Mycobacterial & Respiratory Infections
National Jewish
Denver, Colorado